NIFTY 5023,767.45-0.43%NSE | 24 Jul, 03:31 pm

SENSEX76,059.77-0.43%BSE | 24 Jul, 03:31 pm

NIFTY BANK56,693.50.18%NSE | 24 Jul, 03:31 pm

NIFTY IT28,767.950.82%NSE | 24 Jul, 03:31 pm

S&P 5007,411.980.05%US | 25 Jul, 02:56 am

DOW JONES51,947.250.46%US | 25 Jul, 02:56 am

NASDAQ24,975.82-0.64%US | 25 Jul, 02:45 am

FTSE 10010,736.230.91%UK | 24 Jul, 09:05 pm

NIKKEI 22564,611.15-2.73%JP | 24 Jul, 12:15 pm

HANG SENG24,963.23-0.98%HK | 24 Jul, 01:38 pm

PA

NSE · EQ · EQ

Parmax Pharma Limited PARMAX

NSE:INR 102.8324 Jul, 02:15 pm

BSE:INR 102.8324 Jul, 02:15 pm

-2.09 · -1.99%

Snapshot

Price and key statistics

Reported and computed values remain separate; missing values are not converted to zero.

OpenNot available

Previous closeINR 104.92

Day rangeNot available — Not available

52-week rangeNot available — Not available

VolumeNot available

Market capNot available

P/ENot available

IndustryEQ

ISININE240T01014

Validated OHLC

Interactive price chart

Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.

Open full workspace

PARMAXParmax Pharma Limited1d · INR · NSE

Loading validated candles…

Resolution: 1d nativeOHLC validation passed0 candles loadedWheel: zoom · Shift+wheel: pan

Auditable calculations

Daily technical summary

Calculated in the browser from validated historical candles. This is descriptive research, not a buy or sell recommendation.

Calculating technicals…

Company reporting

Financial statements

IND AS · INR crore

Financial statement rows are unavailable.

Fundamentals

Valuation and ratios

Valuation data unavailable.

Risk and consensus

Source-qualified signals

Risk metrics

Risk metrics unavailable.

Recommendations

Recommendations unavailable.

Analyst count, source and as-of date are not provided; target values should be treated as unverified.

Industry context

Peer comparison

Only peers present in the company profile payload are displayed.

Peer data unavailable in the company profile payload.

Shareholding

Ownership

Ownership data is not present in the normalized source.

Corporate actions

Events

Corporate event data unavailable.

Company intelligence

Latest relevant news

Source, timestamp and external destination are shown. Provider relevance scores are not available.

Relevant company news is unavailable.

Company profile

Business information

Parmax Pharma Limited market prices and historical candles are loaded from the ShareKeyX Supabase market database.

Industry: Not available
Sector: Not available
Website: Not available
Address: Not available
NSE Code: PARMAX
BSE Code: Not available

ShareKeyX intelligence

AI analysis

Versioned forecast unavailable on web

This repository contains no authenticated model-inference API, model version, confidence distribution or forecast timestamp. The Android listing is available; verify report availability, entitlement and pricing inside the app.

Open Google Play

Questions

Stock FAQ

What is the symbol and ISIN of Parmax Pharma Limited?

Parmax Pharma Limited has the symbol PARMAX and ISIN - INE240T01014.

What is the current price of Parmax Pharma Limited?

Parmax Pharma Limited is currently trading at NA.

What are the year high and year low of Parmax Pharma Limited?

Parmax Pharma Limited has a year high of NA and a year low of NA.

What is the market capitalization of Parmax Pharma Limited?

Parmax Pharma Limited has a market capitalization of NA.

What is the P/E ratio of Parmax Pharma Limited?

Parmax Pharma Limited has a P/E ratio of NA.

What is the dividend yield of Parmax Pharma Limited?

Parmax Pharma Limited has a dividend yield of NA.

How is the financial performance of Parmax Pharma Limited based on revenue, net income, and EPS?

Parmax Pharma Limited has revenue of NA, net income of NA, and EPS of NA.

What is the book value of Parmax Pharma Limited?

Parmax Pharma Limited has a book value of NA.

What is the debt-to-equity ratio of Parmax Pharma Limited?

Parmax Pharma Limited has a debt-to-equity ratio of NA.

What are the price-to-book and price-to-sales ratios of Parmax Pharma Limited?

Parmax Pharma Limited has a price-to-book ratio of NA and a price-to-sales ratio of NA.

Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.